Navigation Links
LeMaitre Vascular to Participate in 28th Annual Cowen and Company Health Care Conference
Date:3/11/2008

BURLINGTON, Mass., March 11 /PRNewswire-FirstCall/ -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), which develops, manufactures, and markets medical devices and implants for the treatment of peripheral vascular disease, is scheduled to participate in the 28th Annual Cowen and Company Health Care Conference on Tuesday, March 18, 2008, in Boston.

George W. LeMaitre, Chairman and Chief Executive Officer, and David B. Roberts, President, will provide an update on the company at 10:15 am Eastern Time.

A live audio webcast of the presentation will be available via the Internet at http://ir.lemaitre.com and will be available for replay for approximately three months.

About LeMaitre Vascular

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants for the treatment of peripheral vascular disease. The Company's principal executive offices are located at 63 Second Avenue, Burlington, Massachusetts 01803. Additional information can be found at http://www.lemaitre.com.


'/>"/>
SOURCE LeMaitre Vascular, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. LeMaitre Vascular Acquires Biomateriali, a Vascular Graft Manufacturer
2. LeMaitre Vascular Appoints Russell D. Hays to Its Board of Directors
3. BioVascular, Inc. Expands Executive Team
4. HealthAware Introduces Its VascularAware Cardiovascular Disease Module
5. Topspin Medical Announces First Commercial Installation of the Cathamaran(TM) Intravascular MRI System
6. Escalon(R) Announces FDA 510(K) Clearance for VascuView(TM) Visual Ultrasound System For Assisted Vascular Access
7. Cardica and Intuitive Surgical to Host Educational Symposium on Advanced Techniques and Technologies in Robotic Coronary Revascularization and Mitral Valve Repair
8. The Wisconsin Heart Hospital Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery
9. Boston Scientific Completes Sale of Cardiac Surgery and Vascular Surgery Businesses
10. GlaxoSmithKline Responds to JAMA Article on the ICES Thiazolidinediones and Cardiovascular Outcomes in Older Patients with Diabetes
11. VIA Pharmaceuticals Expands Clinical Advisory Board With Leading Experts in Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... LEXINGTON, Mass. , Sept. 22, 2014 /PRNewswire/ ... GEVA ), a biopharmaceutical company developing ... appointment of Robert Bazemore as Chief ... Patel , President and Chief Executive Officer, Robert ... the company,s lead program, sebelipase alfa for LAL ...
(Date:9/21/2014)... of Basel in Switzerland have succeeded in observing ... for the first time. These extremely weak spectra ... properties and may also contribute to the development ... were published in the scientific journal Nature ... interaction between matter and light, is probably the ...
(Date:9/21/2014)... Chemical Sciences play a significant ... clean air and safe water, healthy food, and ... environmentalists, food scientists, educators, and scientists have a ... field of Chemistry for the national development, and ... of the fastest emerging Sciences, accelerating with a ...
(Date:9/20/2014)... September 20, 2014 HealthTronics, ... and interventional radiology products and services, has signed ... with Clinicon Corporation for its high ... portfolio of minimally invasive, mobile, surgical technology—offering more ... Under the agreement, HealthTronics will make available Clinicon’s ...
Breaking Biology Technology:Synageva BioPharma Appoints Robert Bazemore As Chief Operating Officer 2Synageva BioPharma Appoints Robert Bazemore As Chief Operating Officer 3Synageva BioPharma Appoints Robert Bazemore As Chief Operating Officer 4Uncovering the forbidden side of molecules 2Chemistry for Global Development during the Open Access Week 2Chemistry for Global Development during the Open Access Week 3HealthTronics Announces Distribution Agreement with Clinicon-Laser Surgical Device Expands Minimally Invasive, Mobile Technology Portfolio 2HealthTronics Announces Distribution Agreement with Clinicon-Laser Surgical Device Expands Minimally Invasive, Mobile Technology Portfolio 3
... Consolidated service revenue of $238.7 million grows 32% year-over-year, - ... - Backlog increases ... - Net quarterly book-to-burn ratio ... PRXL ) today announced its financial results for the,second quarter ...
... of Family Cord Blood Banks, LOS ANGELES, ... of California Cryobank, today announced that its co-founder ... appointed to the Department,of Health and Human Services, ... on Blood Stem Cell Transplantation,(ACBSCT). Through his appointment, ...
... required milestone for functional food partners and ... /PRNewswire-FirstCall/ - Neptune Technologies &,Bioressources Inc. ("Neptune") ... Oil ("NKO(R)") has been determined to be,safe ... status required for the,commercialization of NKO(R) incorporated ...
Cached Biology Technology:PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 2PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 3PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 4PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 5PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 6PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 7PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 8PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 9PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results 10Dr. Charles A. Sims of California Cryobank's Family Cord Blood Services Named to National Stem Cell Advisory Council 2Dr. Charles A. Sims of California Cryobank's Family Cord Blood Services Named to National Stem Cell Advisory Council 3Neptune Technologies receives GRAS notification in the United States 2Neptune Technologies receives GRAS notification in the United States 3
(Date:9/21/2014)... team of Stanford researchers has developed a protein therapy ... break away from original tumor sites, travel through the ... the body. , This process, known as metastasis, can ... "The majority of patients who succumb to cancer fall ... Cochran, an associate professor of bioengineering who describes a ...
(Date:9/19/2014)... study multifunctional and specialized spinal cord nerve cells ... Foundation grant in the amount of $680,000 for ... the Department of Biology, OU College of Arts ... the multifunctional and specialized spinal cord nerve cells ... connections they make. Berkowitz will collaborate with ...
(Date:9/19/2014)... A new study shows that legume plants regulate ... cytokininssignaling molecules that are transmitted through the plant ... the number of bacteria-holding nodules in the roots. ... the National Institute for Basic Biology, the Graduate ... Center for Sustainable Resource Science in Japan. ...
Breaking Biology News(10 mins):Stanford researchers create 'evolved' protein that may stop cancer from spreading 2Stanford researchers create 'evolved' protein that may stop cancer from spreading 3Stanford researchers create 'evolved' protein that may stop cancer from spreading 4For legume plants, a new route from shoot to root 2
... motor excitability have a better working memory than humans with ... by scientists from the Transfacultary Research Platform at the University ... drawn as to the general cortical excitability as well ... temporary storage of information such as memorizing a phone number ...
... found new clues to how plants evolved to withstand wintry ... issue of the journal Nature , the team constructed ... plants the largest time-scaled evolutionary tree to date. By ... stem data for thousands of species, the researchers were able ...
... The Scripps Research Institute (TSRI) have demonstrated a drug-discovery ... of chemical compounds that have a desired effect on ... To illustrate the power of the innovative technique, the ... shows promise for treating obesity-linked diabetes. At the same ...
Cached Biology News:Motor excitability predicts working memory 2Study offers clues to how plants evolved to cope with cold 2Study offers clues to how plants evolved to cope with cold 3Innovative screening strategy swiftly uncovers new drug candidates, new biology 2Innovative screening strategy swiftly uncovers new drug candidates, new biology 3Innovative screening strategy swiftly uncovers new drug candidates, new biology 4
... Drosophila S2 cells are used for heterologous ... System (DES). The S2 cell line was ... (20-24 hours old) Drosophila melanogaster embryos ... at room temperature without CO2 and is easily ...
Mouse monoclonal antibody to RAD51L3 - RAD51-like 3 (S. cerevisiae)...
... new product number, created to easily match ... yet, please order under the old Sigma-Aldrich ... assistance. Feature: tissue-culture treated yes ... cm 2 D H 60 ...
... Nop1p/Fibrillarin was originally identified ... yeast, Saccharomyces cerevisiae (accession P15646). The ... viability and is localized in the ... is fibrillarin (accession P22087) a component ...
Biology Products: